AAM is continually adding new reports to our resource area with information on both generics and biosimilars. Below are some of our latest reports below – including data on how generic medicines can increase patient access to needed medicines, why generic medicines are essential to lowering health care costs, and how you can encourage your member of Congress to act in support on generic and biosimilar medicines.
For addition content about biosimilars, we encourage you to visit the Biosimilars Council website and their resources page.
